These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Studies on the demonstration of fetal erythrocytes in the maternal blood during the postpartum period]. Cordier P; Madeline P; Guillaumin JP; Jeanney JC; Couzineau P Ann Biol Clin (Paris); 1967; 25(7):903-11. PubMed ID: 4965531 [No Abstract] [Full Text] [Related]
5. [Foetal erythrocytes in maternal blood and immunoprophylaxis of Rh-immunization. Clinical and experimental studies]. Bartsch FK Acta Obstet Gynecol Scand Suppl; 1972; 20():1-128. PubMed ID: 4632454 [No Abstract] [Full Text] [Related]
6. [On the prevention of Rh immunization in Sweden]. Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799 [No Abstract] [Full Text] [Related]
7. [Demonstration and elimination of HbF cells in mothers after the birth of ABO-incompatible children]. Luboldt W Bibl Haematol; 1969; 32():312-8. PubMed ID: 4981567 [No Abstract] [Full Text] [Related]
8. [The danger of sensitization by miscarriages]. Krebs D Bibl Haematol; 1969; 32():141-3. PubMed ID: 4980800 [No Abstract] [Full Text] [Related]
10. [Massive feto-maternal and materno-fetal hemorrhage]. Valbonesi M; Cinollo G; Rivabella L; Serra G Minerva Pediatr; 1978 Jul; 30(14):1149-52. PubMed ID: 97508 [No Abstract] [Full Text] [Related]
11. [Practical problems of preventing Rh sensitization using immunological methods]. Althoff W; Schellong G; Stahl M Rev Clin Esp; 1969 Sep; 114(6):515-24. PubMed ID: 4988856 [No Abstract] [Full Text] [Related]
12. [Problems of IgG-anti D administration during pregnancy]. Hähn N; Gallasch EH; Smaluhn W; Lüthje D Zentralbl Gynakol; 1974 Jul; 96(29):897-904. PubMed ID: 4213693 [No Abstract] [Full Text] [Related]
13. [Is a wrong determination of the maternal blood group following fetomaternal macrotransfusion possible?]. Preisler O; Schneider J; Sommer D; Kopplow E Zentralbl Gynakol; 1969 Sep; 91(38):1225-7. PubMed ID: 4983834 [No Abstract] [Full Text] [Related]
14. [Immunoprophylaxis in serologic incompatibility]. Gajewska E Pediatr Pol; 1973 Jun; 48(6):771-7. PubMed ID: 4198492 [No Abstract] [Full Text] [Related]
15. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage]. Mattone PG; Meriggi E; De Martin G Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573 [No Abstract] [Full Text] [Related]
16. [Practical questions in the immunological prevention of Rh sensitization]. Althoff W; Schellong G; Stahl M Munch Med Wochenschr; 1969 Jun; 111(25):1386-95. PubMed ID: 4185511 [No Abstract] [Full Text] [Related]
17. [Physiopathology of Rh-prevention. Elimination of rhesus-positive radio-chromium labeled umbilical cord erythrocytes in rhesus-negative persons after application of anti-D-serums]. Schneider J; Leidenberger H; Heimpel H Med Klin; 1970 Apr; 65(15):718-23. PubMed ID: 4108360 [No Abstract] [Full Text] [Related]